| Target Price | $66.30 |
| Price | $45.56 |
| Potential |
45.52%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target Hinge Health 2027 .
The average Hinge Health target price is $66.30.
This is
45.52%
register free of charge
$75.60
65.94%
register free of charge
$48.48
6.41%
register free of charge
|
|
| A rating was issued by 21 analysts: 19 Analysts recommend Hinge Health to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Hinge Health stock has an average upside potential 2027 of
45.52%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 390.40 | 585.31 |
| 33.37% | 49.93% | |
| EBITDA Margin | -4.73% | 19.73% |
| 88.90% | 516.81% | |
| Net Margin | -3.06% | 11.68% |
| 91.73% | 482.22% |
17 Analysts have issued a sales forecast Hinge Health 2025 . The average Hinge Health sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Hinge Health EBITDA forecast 2025. The average Hinge Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 Hinge Health Analysts have issued a net profit forecast 2025. The average Hinge Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.15 | 0.87 |
| 89.21% | 680.00% | |
| P/E | 52.48 | |
| EV/Sales | 5.31 |
17 Analysts have issued a Hinge Health forecast for earnings per share. The average Hinge Health EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Oct 08 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Sep 23 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Sep 11 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Sep 05 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Oct 08 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Sep 23 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Sep 11 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Sep 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


